Recent Finacing
Recent Raise
BioSig Technologies develops the Pure EP system to detect cardiac arrhythmias and support mapping and ablation, undergoing preclinical and first‑in‑human clinical validation at Mayo Clinic and other centers.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at BioSig Technologies.
